To confirm the apoptosis-inducing effect of regorafenib in human CCA cells, after treatment with varying concentrations of this drug, the percentages of apoptotic populations in HuCCT1 and KKU-100 cells were determined by FITC-Annexin V staining and subsequent flow cytometry. The gene discussed is ANXA5; the disease is cholangiocarcinoma.